Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
Status:
Withdrawn
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this project are to examine amyloid burden and cognition in a group of
subjects diagnosed with Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) before
and after a six month course of insulin delivered weekly in a controlled pulsatile
intravenous fashion in a clinical setting. The investigators central hypothesis is
straightforward: The investigators predict that controlled pulsed IV infusion of insulin will
improve cognition in patients with AD, and that this improvement will be correlated with a
decrease in amyloid burden in these patients.
Phase:
N/A
Details
Lead Sponsor:
Louisiana State University Health Sciences Center Shreveport